Why is HIV rarely transmitted by oral secretions?: Saliva can disrupt orally shed, infected leukocytes

Archives of Internal Medicine

Volumn 159, Issue 3, 1999, Pages 303-310

  Baron, Samuel ^a   Poast, Joyce ^a   Cloyd, Miles W ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CYTOLYSIS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEUKOCYTE; PRIORITY JOURNAL; SALIVA; SEMINAL PLASMA; VAGINITIS; VIRUS REPLICATION; VIRUS SHEDDING; VIRUS TRANSMISSION;

ADULT; AGED; FEMALE; HIV INFECTIONS; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; SALIVA;

EID: 0033535130     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.159.3.303     Document Type: Article

References (117)

1. Gooch B, Marianos D, Ciesielski C, et al. Lack of evidence for patient-to-patient transmission of HIV in a dental practice. J Am Dent Assoc. 1993;124:38-44.
2. Moore BE, Flaitz CM, Coppenhaver DH, et al. HIV recovery from saliva before and after dental treatment: inhibitors may have a critical role in viral inactivation. J Am Dent Assoc. 1993;124:67-74.
3. Levy J, Greenspan D. HIV in saliva. Lancet. 1988;2:1248.
4. Richman KM, Rickman LS. The potential for transmission of human immunodeficiency virus through human bites. J Acquir Immune Defic Syndr. 1993;6: 402-406.
5. Ho DD, Byington RE, Schooley RT, Flynn T, Rota TR, Hirsch MS. Infrequency of isolation ot HTLV-III virus from saliva in AIDS. N Engl J Med. 1985;313:1606.
6. Rogers MF, White CR, Sanders R, et al. Lack of transmission of human immunodeficiency virus from infected children to their household contacts. Pediatrics. 1990;85:210-214.
7. Piazza M. Chirianni A, Picciotto L, Cataldo PT, Borgia G, Orlando R. Blood in saliva of patients with acquired immunodeficiency syndrome: possible implication in sexual transmission of the disease. J Med Virol. 1994;42:38-41.
8. Yeung SCH, Kazazi F, Randle CGM, et al. Patients infected with human immunodeficiency virus type 1 have low levels of virus in saliva even in the presence of periodontal disease. J Infect Dis. 1993;167:803-809.
9. Goto Y, Yeh CK, Notkins AL, Prabhakar BS. Detection of proviral sequences in saliva of patients infected with human immunodeficiency virus type 1. AIDS Res Hum Retroviruses. 1991;7:343-347.
10. Qureshi MN, Barr CE, Seshamma T, Reidy J, Pomerantz RJ, Bagasra O. Infection of oral mucosal cells by human immunodeficiency virus type 1 in seropositive persons. J Infect Dis. 1995;171:190-193.
11. Melvin AJ, Tamura GS, House JK. et al. Lack of detection of human immunodeficiency virus type 1 in the saliva of infected children and adolescents. Arch Pediatr Adolesc Med. 1997;151:228-232.
12. Coppenhaver DH, Sriyuktasuth-Woo P, Baron S. Correlation of nonspecific antiviral activity with the ability to isolate infectious HIV-1 from saliva. N Engl J Med. 1994;330:1314-1315.
13. Barr CE, Miller LK, Lopez MR, et al. Recovery of infectious HIV-1 from whole saliva. J Am Dent Assoc. 1992;123:36-37.
14. Zhu T, Wang N, Carr A, et al. Genetic characterization of human immunodeficiency virus type 1 in blood and genital secretions: evidence for viral compartmentalization and selection during sexual transmission. J Virol. 1996;70: 3098-3107.
15. Vernazza PL, Eron JJ, Fiscus SA. Sensitive method for the detection of infectious HIV in semen of seropositive individuals. J Virol Methods. 1996;56: 33-40.
16. Milman G, Sharma O. Mechanisms of HIV/SIV mucosal transmission. AIDS Res Hum Retroviruses. 1994;10:1305-1312.
17. Coombs RW, Colier AC, Allain JP. et al. Plasma viremia in human immunodeficiency virus infection. N Engl J Med. 1989;321:1626-1631.
18. Bouscarat F, Levacher-Clergeot M, Dazza MC, et al. Correlation of CD8 lymphocyte activation with cellular viremia and plasma HIV RNA levels in asymptomatic patients infected by human immunodeficiency virus type 1. AIDS Res Hum Retroviruses. 1996;12:17-24.
19. Simon F, Matheron S, Tamalet C, et al. Cellular and plasma viral load in patients infected with HIV-2. AIDS. 1993;7:1411-1417.
20. Escaich S, Ritter J, Rougier P, et al. Plasma viraemia as a marker of viral replication in HIV-infected individuals. AIDS. 1991;5:1189-1194.
21. Saag MS, Grain MJ, Decker WD, et al. High-level viremia in adults and children infected with human immunodeficiency virus: relation to disease stage and CD4+ lymphocyte levels. J Infect Dis. 1991;164:72-80.
22. Srugo I, Brunell PA, Chelyapov NV, Ho DD, Alam M, Israele V. Virus burden in human immunodeficiency virus type 1-infected children: relationship to disease status and effect of antiviral therapy. Pediatrics. 1991;87:921-925.
23. Burke DS, Fowler AK, Redfield RR, Dilworth S, Oster CN. Isolation of HIV-1 from the blood of seropositive adults: patient stage of illness and sample inoculum size are major determinants of a positive culture: The Walter Reed Retroviral Research Group. J Acquir Immune Defic Syndr. 1990;3:1159-1167.
24. Ariyoshi K, Harwood E, Chiengsong-Popov R, Weber J. Is clearance of HIV-1 viraemia at seroconversion mediated by neutralizing antibodies' Lancet. 1992; 340:1257-1258.
25. Clark SJ, Saag MS, Decker WD. et al. High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection. N Engl J Med. 1991;324: 954-960.
26. Daar ES, Moudgil T, Meyer RD, Ho DD. Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection. N Engl J Med. 1991;324:961-964.
27. Connick E, Marr DG, Zhang X-Q, et al. HIV-specific cellular and humoral immune responses in primary HIV infection. AIDS Res Hum Retroviruses. 1996; 12:1129-1140.
28. Kabat D, Kozak SL, Wehrly K, Chesebro B. Differences in CD4 dependence tor inactivity of laboratory-adapted and primary patient isolates of human immunodeficiency virus type 1. J Virol. 1994;68:2570-2577.
29. Baba TW, Trichel AM, An L, et al. Infection and AIDS in adult macaques after nontraumatic oral exposure to cell-free SIV. Science. 1996;272:1486-1489.
30. Bomsel M. Transcytosis of infectious human immunodeficiency virus across a tight human epithelial cell line barrier. Nat Med. 1997;3:42-47.
31. Zacharopoulos VR, Phillips DM. Cell-mediated HTLV-1 infection of a cervix-derived epithelial cell line. Microb Pathog. 1997;23:225-233.
32. Phillips DM, Bourinbaiar AS. Mechanism of HIV spread from lymphocytes to epithelia. Virology. 1992;186:261-273.
33. Tan X, Phillips DM. Cell-mediated infection of cervix derived epithelial cells with primary isolates of human immunodeficiency virus. Arch Virol. 1996;141: 1177-1189.
34. Frankel SS, Tenner-Racz K, Racz P, et al. Active replication of HIV-1 at the lymphoepithelial surface of the tonsil. Am J Pathol. 1997;151:89-96.
35. Parkhurst MR, Saltzman WM. Leukocytes migrate through three-dimensional gels of midcycle cervical mucus. Cell Immunol. 1994;156:77-94.
36. Spira Al, Marx PA, Patterson BK, et al. Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaques. J Exp Med. 1996;183:215-225.
37. Ibata B, Parr EL, King NJ, Parr MB. Migration of foreign lymphocytes from the mouse vagina into the cervicovaginal mucosa and to the iliac lymph nodes. Biol Peprod. 1997;56:537-543.
38. Archibald DW, Cole GA. In vitro inhibition of HIV-1 infectivity by human salivas. AIDS Res Hum Retroviruses. 1990;6:1425-1432.
39. Coppenhaver DH, Baron JL, McKerlie ML, Sabados J, Baron S. Size and stability of a naturally occurring virus inhibitor. Antimicrob Agents Chemother. 1984; 25:646-649.
40. Fox PC, Wolff A, Yeh C-K, Atkinson JC, Baum BJ. Salivary inhibition of HIV-1 infectivity: functional properties and distribution in men, women, and children. J Am Dent Assoc. 1989;118:709-711.
41. Fox PC, Wolff A, Yeh C-K, Atkinson JC, Baum BJ. Saliva inhibits HIV-1 infectivity. J Am Dent Assoc. 1988;116:635-637.
42. Fultz PN. Components of saliva inactivate human immunodeficiency virus. Lancet. 1986;2:1215.
43. McNeely TB, Dealy M, Dripps DJ, Orenstein JM, Eisenberg SP, Wahl SM. Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro. J Clin Invest. 1995;96: 456-464.
44. McNeely T, Shugars DC, Rosendahl M, Tucker C, Eisenberg SP, Wahl SM. Inhibition of human immunodeficiency virus type 1 infectivity by secretory leukocyte protease inhibitor occurs prior to viral reverse transcription. Blood. 1997; 90:1141-1149.
45. Wahl SM, Orenstein JM. Immune stimulation and HIV-1 viral replication. J Leukoc Biol. 1997;62:67-71.
46. Bergey EJ, Cho MI, Blumberg BM, et al. Interaction of HIV-1 and human salivary mucins. J Acquir Immune Defic Syndr. 1994;7:995-1002.
47. Yeh CK, Handelman B, Fox PC, Baum BJ. Further studies of salivary inhibition of HIV-1 infectivity. J Acquir Immune Defic Syndr. 1992;5:898-903.
48. Crombie R, Silverstein RL, MacLow C. Pearce SFA, Nachman RL, Laurence J. Identification of a CD36-related tnrombospondin 1-binding domain in HIV-1 envelope glycoprotein gp120: relationship to HIV-1-specific inhibitory factors in human saliva. J Exp Med. 1998;187:25-35.
49. Archibald DW, Hebert CA. Salivary detection of HIV-1 antibodies using recombinant HIV-1 peptides. Viral Immunol. 1991;4:17-22.
50. Nagashunmugam T, Friedman HM, Davis C, Kennedy S, Goldstein LT, Malamud D. Human submandibular saliva specifically inhibits HIV type 1. AIDS Res Hum Retroviruses. 1997;13:371-376.
51. Cartry O. Moja P, Quesnel A, Pozzetto B, Lucht FR, Genin C. Quantification of IgA and IgG and specificities of antibodies to viral proteins in parotid saliva at different stages of HIV-1 infection. Clin Exp Immunol. 1997;109:47-53.
52. Wahl SM, Worley P, Jin W, et al. Anatomic dissociation between HIV-1 and its endogenous inhibitor in mucosal tissues. Am J Pathol. 1997;150:1275-1284.
53. Robinovitch MR, Iversen JM, Resnick L. Anti-infectivity activity of human salivary secretions toward human immunodeficiency virus. Crit Rev Oral Biol Med. 1993;4:455-459.
54. Sun D, Arachibald DW, Furth PA. Variation of secretory antibodies in parotid saliva to human immunodeficiency virus type 1 with HIV-1 disease stage. AIDS Res Hum Retroviruses. 1990;6:933-941.
55. Ben-Aryeh H, Fisher M, Szargel R, Laufer D. Composition of whole unstimulated saliva of healthy children: changes with age. Arch Oral Biol. 1990;35: 929-931.
56. Edgar WM. Saliva: its secretion, composition and functions. Br Dent J. 1992; 172:305-312.
57. Williams LM, Cloyd MW. Polymorphic human gene(s) determines differential susceptibility of CD4 lymphocytes to infection by certain HIV-1 isolates. Virology. 1991;184:723-728.
58. Maddon PJ, Dalgleish AG, McDougal JS, Clapham PR, Weiss RA, Axel R. The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell. 1986;47:333-348.
59. Goldstein S, Hague B, Montefiori D, Hirscb VM. A macaque adherent cell line that expresses human CD4 is susceptible to SIV: utility for assessing neutralizing antibody. J Virol Methods. 1995;53:139-148.
60. McKeating JA, McKnight A, McIntosh K, Clapham PR, Mulder C, Weiss RA. Evaluation of human and simian immunodeficiency virus plaque and neutralization assays. J Gen Virol. 1989;70:3327-3333.
61. Jones KH, Senft JA. An improved method to determine cell viability by simultaneous staining with fluorescein diacetate-propidium iodide. J Histochem Cytochem. 1985;33:77-79.
62. Krause AW, Carley WW, Webb WW. Fluorescent erythrosin B is preferable to trypan blue as a vital exclusion dye for mammalian cells in monolayer culture. J Histocnem Cytochem. 1984;32:1084-1090.
63. Rozenfarb N, Kupietzky A, Shey Z. Milk and egg albumen are superior to human saliva in preserving human skin fibroblasts. Pediatr Dent. 1997;19:347-348.
64. Blomlof L, Otteskog P. Viability of human periodontal ligament cells after storage in milk or saliva. Scand J Dent Res. 1980;88:436-440.
65. Moore BE. Survival of human immunodeficiency virus (HIV), HIV-infected lymphocytes, and poliovirus in water. Appl Environ Microbiol. 1993;59:1437-1443.
66. Lagerlof F, Dawes C. The volume of saliva in the mouth before and after swallowing. J Dent Res. 1984;63:618-621.
67. Pauza CD, Emau P, Salvato MS, et al. Pathogenesis of SIVmac251 after a traumatic inoculation of the rectal mucosa in rhesus monkeys. J Med Primatol. 1993; 22:154-161.
68. Pauza CD, Malkovsky M, Salvato MS. SIV transmission across the mucosal barrier. AIDS Res Hum Retroviruses. 1994;10:S7-S10.
69. Miller CJ, Alexander NJ, Sutjipto S, et al. Genital mucosal transmission of simian immunodeficiency virus: animal model for heterosexual transmission of human immunodeficiency virus. J Virol. 1989;63:4277-4284.
70. Miller CJ, Alexander NJ, Sutjipto S, et al. Effect of virus dose and nonoxynol-9 on the genital transmission of SIV in rhesus macaques. J Med Primatol. 1990; 19:401-409.
71. Miller CJ, Marthas M, Torten J, et al. Intravaginal inoculation of rhesus macaques with cell-free simian immunodeficiency virus results in persistent or transient viremia. J Virol. 1994;68:6391-6400.
72. Miller CJ. Animal models of viral sexually transmitted diseases. Am J Reprod Immunol. 1994;31:52-63.
73. Marthas ML, Miller CJ, Sutjipto S, et al. Efficacy of live-attenuated and whole-inactivated simian immunodeficiency virus vaccines against vaginal challenge with virulent SIV. J Med Primatol. 1992;21:99-107.
74. Sarkadi B, Mack E, Rothstein A. Ionic events during the volume response of human peripheral blood lymphocytes to hypotonic media, II: volume- and time-dependent activation and inactivation of ion transport pathways. J Gen Physiol. 1984;83:513-527.
75. Deutsch C, Slater L, Goldstein P. Volume regulation of human peripheral blood lymphocytes and stimulated proliferation of volume-adapted cells. Biochim Biophys Acta. 1982;721:262-267.
76. Ruhfus B, Tinel H, Kinne RK. Role of G-proteins in the regulation of organic osmolyte efflux from isolated rat renal inner medullary collecting duct cells. Pflugers Arch. 1996;433:35-41.
77. Summers JC, Trais L, Lajvardi R, et al. Role of concentration and size of intracellular macromolecules in cell volume regulation. Am J Physiol. 1997;273: C360-C370.
78. Grinstein S, Foskett JK. Ionic mechanisms of cell volume regulation in leukocytes. Annu Rev Physiol. 1990;52:399-414.
79. Kovac L, Bohmerova E, Necas O. The plasma membrane of yeast protoplasts exposed to hypotonicity becomes porous but does not disintegrate in the presence of protons or polyvalent cations. Biochim Biophys Acta. 1987;899:265-275.
80. Vernazza PL, Gilliam BL, Dyer J, et al. Quantification of HIV in semen: correlation with antiviral treatment and immune status. AIDS. 1997;11:987-993.
81. Vernazza PL, Eron JJ, Cohen MS, van der Horst CM, Troiani L, Fiscus SA. Detection and biologic characterization of infectious HIV-1 in semen of seropositive men. AIDS. 1994;8:1325-1329.
82. Casson LW, Sorber CA, Palmer RH, Enrico A, Gupta P. HIV survivability in wastewater. Water Environ Res. 1992;64:213-215.
83. Slade JS, Pike EB, Eglia RP, Colbourne JS, Kurtz JB. The survival of human immunodeficiency virus in water, sewage, and seawater. Water Sci Technol. 1989;21:55-59.
84. Transmission of HIV by human bite. Lancet. 1987;2:522.
85. Susuki T, Yoshie H, Jeannel D, et al. Detection of intracellular p24-positive macrophages in gingival crevicular fluid from periodontal lesions of stage IV AIDS patients. AIDS. 1996;10:804-805.
86. Chebbi F, Poveda JD, Suzuki T, et al. Search for infectious HIV in gingival crevicular fluid and saliva of advanced AIDS patients with severe periodontitis. AIDS. 1997;11:927-928.
87. White K, Benjamin W, Hill R. Human basic tear fluid osmolality, I: importance of sample collection strategy. Acta Ophthalmol Scand Suppl. 1993;71:524-529.
88. Eichner H, Behbehani AA, Hochstrasser K. Diagnostic value of nasal secretions, current state: normal values, 1. Laryngorhinootologie. 1983;62:561-565.
89. Cavaliere F, Masieri S, Vagnono S, Proietti R, Magalini SI. Airway secretion electrolytes: reflection of water and salt states of the body. Crit Care Med. 1989; 17:891-894.
90. Ehrnst A, Sonnerborg A, Bergdahl S, Strannegard O. Efficient isolation of HIV from plasma during different stages of HIV infection. J Med Virol. 1988;26:23-32.
91. Ho DD, Moudgil T, Alam M. Quantitation of human immunodeficiency virus type 1 in the blood of infected persons. N Engl J Med. 1989;321:1621-1625.
92. Anderson DJ, O'Brien TR, Politch JA, et al. Effects of disease stage and zidovudine therapy on the detection of human immunodeficiency virus type 1 in semen. JAMA. 1992;267:2769-2774.
93. Royce RA, Sena A, Cates W Jr, Cohen MS. Sexual transmission of HIV. N Engl J Med. 1997;336:1072-1078.
94. Cao Y, Krogstad P, Korber BT, et al. Maternal HIV-1 viral load and vertical transmission of infection: the Ariel Project for the prevention of HIV transmission from mother to infant. Nat Med. 1997;3:549-552.
95. Black RF. Transmission of HIV-1 in the breast-feeding process. J Am Diet Assoc. 1996;96:267-274.
96. Dunn DT, Newell ML, Ades AE, Peckham CS. Risk of human immunodeficiency virus type 1 transmission through breastfeeding. Lancet. 1992;340: 585-588.
97. Ryder RW, Manzila T, Baende E, et al. Evidence from Zaire that breast-feeding by HIV-1-seropositive mothers is not a major route for perinatal HIV-1 transmission but does decrease morbidity. AIDS. 1991;5:709-714.
98. Bertolli J, Louis ME, Simonds RJ, et al. Estimating the timing of mother-to-child transmission of human immunodeficiency virus in a breast-feeding population in Kinshasa, Zaire. J Infect Dis. 1996;174:722-726.
99. Levy JA. The transmission of AIDS: the case of the infected cell. JAMA. 1988; 260:3586-3587.
100. Goldman AS, Goldblum RM. Transfer of maternal leukocytes to the infant by human milk. In: Olding LB, ed. Reproductive Immunology. New York, NY: Springer Publishing Co Inc; 1996:205-213.
101. Buranasin P, Kunakorn M, Petchclai B, et al. Detection of human immunodeficiency virus type 1 (HIV-1) proviral DNA in breast milk and colostrum of seropositive mothers. J Med Assoc Thai. 1993;76:41-45.
102. Vonesch N, Sturchio E, Humani AC, et al. Detection of HIV-1 genome in leukocytes of human colostrum from anti-HIV-1 seropositive mothers. AIDS Res Hum Retroviruses. 1992;8:1283-1287.
103. Mohor JA. The possible induction of cellular hypersensitivity associated with ingestion of colostrum. J Pediatr. 1973;82:1062-1064.
104. Nakano S, Ando Y, Saito K, et al. Primary infection of Japanese infants with adult T-cell leukaemia-associated retrovirus (ATLV): evidence for viral transmission from mothers to children. J Infect. 1986;12:205-212.
105. Ando Y, Kakimoto K, Tanigawa T, et al. Effect of freeze-thawing breast milk on vertical HTLV-I transmission from seropositive mothers to children. Jpn J Cancer Res. 1989;80:405-407.
106. Orloff SL, Wallingford JC, McDougal JS. Inactivation of human immunodeficiency virus type 1 in human milk: effects of intrinsic factors in human milk and of pasteurization. J Hum Lact. 1993;9:13-17.
107. Quatro M, Germinario C, Troiano T, et al. HIV transmission by fellatio. Eur J Epidemiol. 1990;6:339-340.
108. Lifson AR, O'Malley PM, Hessol NA, Buchbinder SP, Cannon L, Ritherford GW. HIV seroconversion in two homosexual men after receptive oral intercourse with ejaculation: implications for counseling concerning safe sexual practices. Am J Public Health. 1990;80:1509-1511.
109. Mayer KH, DeGruttola V. Human immunodeficiency virus and oral intercourse. Ann Intern Med. 1987;107:428-429.
110. Lane HC, Holmberg SD, Jaffe HW. HIV seroconversion and oral intercourse. Am J Public Health. 1991;81:658.
111. Berrey MM, Shea T. Oral sex and HIV transmission. J Acquir Immune Defic Syndr Hum Retrovirol. 1997;14:475-477.
112. Keet IP, Albrecht van Lent N, Sandfort TG. Countinho RA, van Griensven GJ. Orogenital sex and the transmission of HIV among homosexual men. AIDS. 1992; 6:223-226.
113. Girgis SM, Hafiez AA, Mittawy B, Hamza KH. Electrolyte concentration in semen. Andrologia. 1980;12:323-327.
114. Mehl M. Change in sodium and potassium concentration in human seminal plasma infected experimentally with ureaplasma urealyticum. Andrologia. 1986;18: 224-229.
115. Kavanagh J. Sodium, potassium, calcium, magnesium, zinc, citrate and chloride content of human prostatic and seminal fluid. J Reprod Fertil. 1985;75: 35-41.
116. Auger J, Kunstmann JM, Czyglik F, Jouannet P. Decline in semen quality among fertile men in Paris during the past 20 years. N Engl J Med. 1995;332:281-285.
117. Osegbe DN, Amaku EO, Nnatu SN. Are changing semen parameters a universal phenomenon? Eur Urol. 1986;12:164-168.